SSRI antidepressants explained — why they work for one person and not another

What an SSRI actually does — and what it doesn't

An SSRI doesn't produce new serotonin. It blocks the serotonin transporter (SERT) — the protein that pulls released serotonin back into the nerve cell. When SERT is blocked, serotonin stays in the synaptic cleft longer and its signal is stronger.

The older theory of depression as a "simple serotonin deficiency" no longer holds. The real effect of SSRIs is more complex — it also involves receptor adaptation (down-regulation of 5-HT1A autoreceptors over 2–4 weeks), support for neuroplasticity via BDNF (brain-derived neurotrophic factor), regulation of the HPA stress axis, and sleep quality. That's why the full effect only appears after weeks, not right after the first pill — and that delay is exactly why the dose usually isn't changed during the first 4–6 weeks, even if the effect isn't felt yet.

Different SSRIs differ from one another more than they might seem — and not just by name. Sertraline has a milder effect on appetite and is often a first choice with comorbid anxiety. Escitalopram has the cleanest mechanism in the whole class (the fewest side bindings to other receptors) and tends to be better tolerated in older clients. Fluoxetine has a very long half-life (weeks), which means a gentler onset and a gentler withdrawal, but also slower dose fine-tuning. Paroxetine is the most sedating, but has the most pronounced withdrawal symptoms if a dose is missed. Citalopram is similar to escitalopram, but at higher doses carries a risk of QT-interval prolongation on the heart, which is why it has a set dose ceiling.

Who tends to respond best to SSRIs

According to the orthomolecular approach, SSRIs work best for people with an undermethylated profile — a picture that includes rumination (thoughts that loop over and over), obsessive thinking, perfectionism, inner tension, seasonal allergies, and a more competitive streak. This picture is typically associated with increased SERT activity — the "vacuum" is running at full power, functional serotonin in the synapse is low, and blocking it with an SSRI therefore makes sense.

A standard psychiatric diagnosis (e.g. "major depressive disorder") on its own does not predict SSRI response — two people with the same diagnosis can have completely opposite underlying biochemistry. We cover this distinction in more detail in Histadelia vs. histapenia — opposite states.

In practice this means two people with the same depression "label" can have opposite biochemical needs — while one responds to an SSRI within three weeks with marked relief, the other may feel "more unsettled," more irritable, or more fatigued, even though the medication and dose are identical. This different behavior of the same drug is exactly what a diagnosis alone cannot predict.

Why SSRIs sometimes make anxiety worse

Worsening anxiety after starting an SSRI has several possible biochemical explanations:

• Overmethylation — if synaptic serotonin is already high, adding an SSRI worsens the situation instead of improving it; typically accompanied by anxiety, an inner tremor, insomnia, and heightened sensitivity to medications in general.
• Copper overload — here anxiety is driven by excess norepinephrine, not a serotonin shortage. An SSRI doesn't target this mechanism at all, so anxiety doesn't ease and new panic can sometimes appear.
• Pyroluria — low zinc and B6 limit the production of the neurotransmitters an SSRI needs as "raw material" for its effect; pyroluria is also commonly associated with heightened sensitivity to any centrally acting medication.
• Initial activation — the first weeks of treatment can temporarily increase restlessness, tremor, or insomnia while the system adapts; this differs from a lasting worsening and usually resolves within 2–3 weeks.

Activation at the start of treatment deserves particular attention in young adults — in the first weeks of treatment (especially under age 25), mood and any thoughts of self-harm need to be monitored; this is a standard clinical precaution, not a reason to panic, but it is a reason to stay in close contact with the prescribing doctor.

The choice, tolerability, and any change of medication is decided solely by the treating physician or psychiatrist.

Common side effects and what to do about them

The first 1–2 weeks of an SSRI are often accompanied by mild nausea, headache, fatigue, or changes in appetite — for most people these settle down. Longer-lasting and less often discussed issues include sexual dysfunction (reduced libido, delayed orgasm — affecting, by some studies, 30–60% of users, and often not resolving on its own until the medication or dose changes), emotional "blunting" (a sense of reduced emotional intensity, both positive and negative), and night sweats.

These effects are not "just in your head," and it's worth discussing them openly with the prescribing doctor — there are strategies (changing the time of dosing, switching medication within the class, add-on treatment) that can ease them without needing to stop treatment altogether.

Why an SSRI can stop working over time

Temporary relief that fades after months is a common complaint — sometimes called "SSRI poop-out" or tachyphylaxis. Possible explanations: persistent, untreated undermethylation, rising copper, falling zinc, worsening pyroluria, vitamin D deficiency, chronic sleep deprivation, toxic burden, or elevated SAH (S-adenosylhomocysteine) — all factors that can recreate the original "low serotonin" state the medication was originally working against.

When these causes go unaddressed, a common next step is adding more medications to manage the side effects instead of addressing the root cause. The Walsh approach instead recommends testing methylation, histamine, zinc, copper, and pyrroles before adding another medication.

Lab tests that give an answer

The most useful tests when asking "why isn't my SSRI working, or why did it stop working": whole-blood histamine (an indirect marker of methylation), a plasma methylation panel (SAM, SAH, methionine, homocysteine), plasma zinc, serum copper and ceruloplasmin, and urine pyrroles.

A detailed guide to when whole-blood histamine is enough and when a plasma methylation panel is needed is in the article Whole-blood histamine vs. plasma methylation testing.

Never stop suddenly

Abruptly stopping an SSRI can cause what's known as discontinuation syndrome — dizziness, a sensation of "electric shocks" in the head, irritability, nausea, flu-like symptoms, and the return or worsening of the original symptoms. The risk is higher with shorter half-life medications (paroxetine, venlafaxine) than with fluoxetine. Any dose reduction or discontinuation is always decided by the treating doctor, done gradually and under supervision — never on your own. The detailed process is described in the article How to safely discontinue antidepressants.

A practical first step

1. Fill out the free 5-minute screening — it will indicate which of the five biotypes is likely in play.

2. If undermethylation or overmethylation is suspected, order a whole-blood histamine test (€149).

3. Once you have the result, book a 45-minute consultation (€75) — we'll go through the findings and what's worth discussing with your psychiatrist. PsyLab is not a psychiatric practice, and any change or discontinuation of medication is always decided by your treating doctor.

You can read more about the mechanism behind matching a medication to methylation status in the article Antidepressants and methylation, and for an overview of all medication classes, see Which depression medication fits your biotype.